# |
PMID |
Sentence |
1 |
14679086
|
Mutation scan of a type 1 diabetes candidate gene: the human interleukin-18 binding protein gene.
|
2 |
14679086
|
IL-18 is capable of inducing T lymphocyte synthesis of IFNgamma, thereby skewing the T helper response toward a T helper type 1 (Th1) profile.
|
3 |
14679086
|
IL-18 binding protein (IL18BP) neutralizes IL-18 and leads to a reduced Th1 response.
|
4 |
14679086
|
Polymorphisms in IL18BP may affect the activity of IL-18 and the magnitude of the Th1 response and may play a role in the pathogenesis of T1DM.
|
5 |
14679086
|
Mutation scan of a type 1 diabetes candidate gene: the human interleukin-18 binding protein gene.
|
6 |
14679086
|
IL-18 is capable of inducing T lymphocyte synthesis of IFNgamma, thereby skewing the T helper response toward a T helper type 1 (Th1) profile.
|
7 |
14679086
|
IL-18 binding protein (IL18BP) neutralizes IL-18 and leads to a reduced Th1 response.
|
8 |
14679086
|
Polymorphisms in IL18BP may affect the activity of IL-18 and the magnitude of the Th1 response and may play a role in the pathogenesis of T1DM.
|
9 |
14679086
|
Mutation scan of a type 1 diabetes candidate gene: the human interleukin-18 binding protein gene.
|
10 |
14679086
|
IL-18 is capable of inducing T lymphocyte synthesis of IFNgamma, thereby skewing the T helper response toward a T helper type 1 (Th1) profile.
|
11 |
14679086
|
IL-18 binding protein (IL18BP) neutralizes IL-18 and leads to a reduced Th1 response.
|
12 |
14679086
|
Polymorphisms in IL18BP may affect the activity of IL-18 and the magnitude of the Th1 response and may play a role in the pathogenesis of T1DM.
|
13 |
15870024
|
IL-18 is a type 1 pro-inflammatory cytokine with structural similarities to IL-1 and in synergy with IL-12 stimulates IFN-gamma production from T lymphocytes and polarizes development and function of Th1 cells.
|
14 |
15870024
|
Because IL-1, IFN-gamma, and up-regulated Th1-mediated events are involved in the pathogenesis of both human and rodent type 1 diabetes mellitus, we have evaluated the effects of a specific inhibitor of IL-18 (the IL-18bp:FcIg) on the development of accelerated forms of autoimmune diabetes in NOD mice.
|
15 |
17075045
|
By neutralizing IL-18 activity with IL-18 binding protein (IL-18BP), we observed that islets produce bioactive IL-18.
|
16 |
17075045
|
In related studies, IL-18R-deficient splenocytes and macrophages produced 2- to 3-fold greater amounts of IL-18, TNFalpha, macrophage inflammatory protein 1, macrophage inflammatory protein 2, and IFNgamma upon stimulation with Con A, Toll-like receptor 2 agonist, or anti-CD3 antibodies.
|
17 |
17075045
|
Importantly, discrepancies between IL-18- and IL-18R-deficient cells suggest that IL-18Ralpha chain is used by an inflammation-suppressing signal.
|
18 |
21440322
|
Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy.
|